Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Marra

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Drugs in R&D|April 20, 2006
Targeting virulence for antibacterial chemotherapy: identifying and characterising virulence factors for lead discoveryAndrea Marra
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2013
Animal models in drug development for MRSAAndrea Marra
Future Microbiology|March 4, 2011
NDM-1: a local clone emerges with worldwide aspirationsAndrea Marra
Future Microbiology|July 30, 2011
Antibacterial resistance: is there a way out of the woods?Andrea Marra
Expert Review of Anti-Infective Therapy|October 16, 2004
Can virulence factors be viable antibacterial targets?Andrea Marra
Methods in Molecular Biology (Clifton, N.J.)|September 17, 2019
Animal Models for Drug Development for MRSAAndrea Marra
Current Protocols in Pharmacology|September 29, 2011
Primary rodent infection models for testing antibacterial compound efficacy in vivoAndrea Marra, Dennis Girard
Blood|April 17, 2020
Placental myeloid sarcomaAndrea Marra, Giovanni Martino
Expert Review of Anti-Infective Therapy|July 1, 2008
Acinetobacter baumannii: an emerging multidrug-resistant threatThomas D Gootz, Andrea Marra
Annals of Hematology|November 15, 2018
Uncommon lymphoplasmacytic lymphoma with IgA paraproteinemia: a challenging clinical diagnosis solved by MYD88 mutation analysisGiovanni Martino, Andrea Marra, Stefano Ascani, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Drugs in R&D|April 20, 2006
Targeting virulence for antibacterial chemotherapy: identifying and characterising virulence factors for lead discoveryAndrea Marra
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2013
Animal models in drug development for MRSAAndrea Marra
Future Microbiology|March 4, 2011
NDM-1: a local clone emerges with worldwide aspirationsAndrea Marra
Future Microbiology|July 30, 2011
Antibacterial resistance: is there a way out of the woods?Andrea Marra
Expert Review of Anti-Infective Therapy|October 16, 2004
Can virulence factors be viable antibacterial targets?Andrea Marra
Methods in Molecular Biology (Clifton, N.J.)|September 17, 2019
Animal Models for Drug Development for MRSAAndrea Marra
Current Protocols in Pharmacology|September 29, 2011
Primary rodent infection models for testing antibacterial compound efficacy in vivoAndrea Marra, Dennis Girard
Blood|April 17, 2020
Placental myeloid sarcomaAndrea Marra, Giovanni Martino
Expert Review of Anti-Infective Therapy|July 1, 2008
Acinetobacter baumannii: an emerging multidrug-resistant threatThomas D Gootz, Andrea Marra
Annals of Hematology|November 15, 2018
Uncommon lymphoplasmacytic lymphoma with IgA paraproteinemia: a challenging clinical diagnosis solved by MYD88 mutation analysisGiovanni Martino, Andrea Marra, Stefano Ascani, et al.
Pageof 6